Tarceva in pancreatic cancer was in combination with Gemcitabine vs Gemcitabine alone, so it was against active treatment not placebo, the burden is different. Both PFS and OS achieved stat significant here as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.